| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-12 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |